Katrien Lagrou

27.9k total citations · 2 hit papers
297 papers, 9.2k citations indexed

About

Katrien Lagrou is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katrien Lagrou has authored 297 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Infectious Diseases, 193 papers in Epidemiology and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katrien Lagrou's work include Antifungal resistance and susceptibility (164 papers), Fungal Infections and Studies (126 papers) and Pneumocystis jirovecii pneumonia detection and treatment (38 papers). Katrien Lagrou is often cited by papers focused on Antifungal resistance and susceptibility (164 papers), Fungal Infections and Studies (126 papers) and Pneumocystis jirovecii pneumonia detection and treatment (38 papers). Katrien Lagrou collaborates with scholars based in Belgium, Netherlands and France. Katrien Lagrou's co-authors include Johan Maertens, Wouter Meersseman, Johan Van Eldere, Jan Verhaegen, Isabel Spriet, Marc Van Ranst, Eric Verbeken, Paul E. Verweij, Eric Van Wijngaerden and Patrick Van Dijck and has published in prestigious journals such as The Lancet, Blood and The Journal of Immunology.

In The Last Decade

Katrien Lagrou

286 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

2011 540 citations Katrien Lagrou, Cornelia Lass‐Flörl et al. profile →
Pathogenesis and management of fracture-related infection

2019 186 citations Katrien Lagrou et al. profile →

Peers

Countries citing papers authored by Katrien Lagrou

Since Specialization

Citations

This map shows the geographic impact of Katrien Lagrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Lagrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Lagrou more than expected).

Fields of papers citing papers by Katrien Lagrou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Lagrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Lagrou. The network helps show where Katrien Lagrou may publish in the future.

Co-authorship network of co-authors of Katrien Lagrou

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Lagrou. A scholar is included among the top collaborators of Katrien Lagrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Lagrou. Katrien Lagrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance? 2025 ·mBio ·Hans Carolus, Judith Díaz-García, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pilar Escribano, (unknown), Katrien Lagrou, Christian R. Landry, Toni Gabaldón, Patrick Van Dijck	0
2	Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients 2024 ·Infection ·(unknown), (unknown), (unknown), Matthias Gijsen, Willy Peetermans, Eric Van Wijngaerden, Stefanie Desmet, Katrien Lagrou, Peter Declercq, (unknown), Isabel Spriet	0
3	Quantitative MRI of a Cerebral Cryptococcoma Mouse Model for In Vivo Distinction between Different Cryptococcal Molecular Types 2024 ·Journal of Fungi ·(unknown), (unknown), (unknown), (unknown), Anca Sava, (unknown), Willy Gsell, Greetje Vande Velde, Katrien Lagrou, Wieland Meyer, Uwe Himmelreich	1
4	Aspergillus Fumigatus Spore Proteases Alter the Respiratory Mucosa Architecture and Facilitate Equine Herpesvirus 1 Infection 2024 ·Viruses ·(unknown), (unknown), Wim Van Den Broeck, Katrien Lagrou, Kathlyn Laval, Hans Nauwynck	2
5	SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients 2023 ·Journal of Medical Virology ·(unknown), (unknown), Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, Filip Rega, Laurens J. Ceulemans, Dirk Van Raemdonck, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Tim Vanuytsel, Pieter Gillard, Hélène Schoemans, Johan Van Cleemput, Dirk Kuypers, Robin Vos, Frederik Nevens, Jef Verbeek	10
6	Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection 2022 ·Diagnostic Microbiology and Infectious Disease ·Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, Yannick Vande Weygaerde, Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel André, Elizaveta Padalko, Katrien Lagrou, Stien Vandendriessche, Pieter Vermeersch	54
7	Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection 2021 ·Journal of Clinical Virology ·Jan Van Elslande, Matthijs Oyaert, (unknown), Marc Van Ranst, Natalie Lorent, Yannick Vande Weygaerde, Emmanuel André, Katrien Lagrou, Stien Vandendriessche, Pieter Vermeersch	92
8	Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics 2021 ·Mycoses ·Ruth Van Daele, Yves Debaveye, Robin Vos, Pascal Van Bleyenbergh, Roger J. M. Brüggemann, Erwin Dreesen, (unknown), Henk‐Jan Guchelaar, Pieter Vermeersch, Katrien Lagrou, Isabel Spriet	3
9	Comparison of the Quantitative DiaSorin Liaison Antigen Test to Reverse Transcription-PCR for the Diagnosis of COVID-19 in Symptomatic and Asymptomatic Outpatients 2021 ·Journal of Clinical Microbiology ·(unknown), Christophe Indevuyst, Lize Cuypers, (unknown), Nicolas Yin, Frédéric Cotton, Elizaveta Padalko, Matthijs Oyaert, Julie Descy, Étienne Cavalier, Marc Van Ranst, Emmanuel André, Katrien Lagrou, Pieter Vermeersch	25
10	Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society 2020 ·Fetal Diagnosis and Therapy ·Jan Deprest, Mahesh Choolani, Frank A. Chervenak, Diana L. Farmer, Katrien Lagrou, Enrico Lopriore, Laurence B. McCullough, Olutoyin A. Olutoye, Lynn L. Simpson, Tim Van Mieghem, Greg Ryan	26
11	Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM Excellence Center Study 2020 ·Journal of Fungi ·Toine Mercier, (unknown), Maud Gits‐Muselli, Samia Hamane, Juergen Prattes, Harald H. Kessler, Ivana Mareković, (unknown), Jörg Steinmann, Ulrike Scharmann, Johan Maertens, Katrien Lagrou, Blandine Denis, Stéphane Bretagne, Alexandre Alanio	14
12	Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance 2020 ·Journal of Fungi ·Hans Carolus, Siebe Pierson, Katrien Lagrou, Patrick Van Dijck	203
13	Solid organ donation after death from listeria encephalitis: A case report 2020 ·Transplant Infectious Disease ·(unknown), Katrien Lagrou, Ina Jochmans, Mauricio Sainz‐Barriga, Diethard Monbaliu, Jacques Pirenne, Yves Debaveye	3
14	Belgian national survey on tinea capitis: epidemiology and molecular investigations 2019 ·Open Repository and Bibliography (University of Liège) ·Rosalie Sacheli, (unknown), (unknown), (unknown), (unknown), Josette André, (unknown), Katrien Lagrou, (unknown), (unknown), (unknown), (unknown), Laurence Seidel, Marie‐Pierre Hayette	1
15	Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies 2018 ·Journal of Antimicrobial Chemotherapy ·(unknown), Michelle Holtappels, Wafi Siala, Mohamed Lamkanfi, Françoise Van Bambeke, Katrien Lagrou, Patrick Van Dijck, Soňa Kucharíková	20
16	Proteomic Differences between Azole-Susceptible and -Resistant <i>Aspergillus fumigatus</i> Strains 2018 ·Advances in Microbiology ·Edith Vermeulen, Sébastien Carpentier, Olaf Kniemeyer, Machteld Sillen, Johan Maertens, Katrien Lagrou	3
17	Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms 2017 ·Antimicrobial Agents and Chemotherapy ·Michelle Holtappels, Erwin Swinnen, Lies De Groef, (unknown), Lieve Moons, Katrien Lagrou, Patrick Van Dijck, Soňa Kucharíková	10
18	First‐in‐man observation of Talaromyces marneffei ‐transmission by organ transplantation 2016 ·Mycoses ·Frederik Hermans, Sien Ombelet, (unknown), Dries Testelmans, Dirk Van Raemdonck, Geert M. Verleden, Eric Verbeken, Pascal Van Bleyenbergh, Katrien Lagrou, Robin Vos	16
19	PCR-based detection of A. fumigatus cyp51A mutations on bronchoalveolar lavage can readily predict azole treatment failure. A multi-center validation study in 201 hematology patients with suspected invasive aspergillosis 2015 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), (unknown), (unknown), Jerina Boelens, (unknown), Greetje A. Kampinga, Lambert F. R. Span, Katrien Lagrou, (unknown), Gijs Dingemans, Giel R. Gaajetaan, (unknown), Alieke G. Vonk, Bart Rijnders	1
20	Clinical performance of FXG: RESP (Asp+) assay for Pneumocystis jirovecii on respiratory specimens 2008 ·Lirias (KU Leuven) ·Philippe M. Hauser, Katrien Lagrou, (unknown), Cornelia Lass‐Flörl, David S. Perlin, (unknown), Johan Maertens, Michael Hughes, Paul Bowyer, David W. Denning, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact